Skip to content
April 24, 2024

Equity.Guru

Investment information for the new generation

Search

Tetra

Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
A Genetic Link I recently started watching Netflix’s Archive 81 with my girlfriend. Although we have only watched the first episode, there is a clear focus on mental health. It…
Not So Constipated Market I owe Flinstones Gummies my life. That’s a bit of an exaggeration, however, there’s no denying I cared more for my health as a kid…
Tetra Bio-Pharma (TBP.T) (“Tetra”) is a biopharmaceutical company focused on cannabinoid-derived drug discovery and development. The Company has an FDA and Health Canada cleared clinical program intended to bring…
Tetra Bio-Pharma (TBP.T) announced today that the Central Ethics Committee has approved the proposed protocol modifications allowing additional immediate release oral opioids to be used as a comparator in…
Tetra Bio-Pharma (TBP.T) announced that their new investigation new drug (IND) ARDS-003 has been studied in a viral infected organoid model as part of a research collaboration between Targeted Pharmaceuticals…
Tetra Bio-Pharma (TBP.T) announced they are accelerating their PLENITUDE Phase II clinical trial, which is studying QIXLEEF. QIXLEEF is Tetra’s proprietary drug formulation which contains THC and CBD and…
Tetra Bio-Pharma (TBP.T), a leader in cannabinoid-derived drug discovery and development, has announced that is has signed a Definitive Agreement with DanCann Pharma for the exclusive distribution of Reduvo™…
Another day, another Tetra Bio-Pharma (TBP.T) news release. A day after they were granted a Drug Establishment Licence by Health Canada for their REDUVO soft gel capsules, Tetra announced…